Release Date: January 24, 2025
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Q: Can you clarify if the noninterest income outlook excludes the impact of Penns Woods and what's driving that growth? A: Yes, all guidance excludes the impact from Penns Woods. We are focused on driving better and more consistent fee income performance strategically within the firm. This includes transparency about our fee income targets due to unique items like securities restructuring.
Q: How have recent rate movements affected your expected tangible book value dilution and purchase accounting with the Penns Woods acquisition? A: We are not providing updated guidance on the Penns Woods acquisition until closer to the closing date, as these factors will change with our stock price fluctuations.
Q: After cleaning up the credit book, can you update us on the health care portfolio's credit quality and any other areas of concern? A: Most stress in the long-term health care portfolio has been addressed. We expect to execute transactions to remove certain credits from our books in the first quarter. We have no concerns in other sectors and are entering the year in a stable position.
Q: What is the outlook for loan growth, particularly in the commercial sector, and how does it affect net loan growth? A: We see decent pipeline strength in commercial loans and expect a more constructive environment in 2025. We aim for balanced growth, focusing on commercial and consumer loans, and anticipate picking up momentum later in the year.
Q: What are your expectations for loan and deposit betas, and do you foresee an upward bias to the net interest margin (NIM) given the yield curve? A: We see opportunities to benefit from the current rate environment and yield curve. We aim to maintain loan yields and improve margins by focusing on good pricing and terms. We expect continued margin growth in the $3.30 to $3.40 range, even with potential rate cuts.
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
This article first appeared on GuruFocus.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.